1-4 of 4
Eva-Maria Reitter
Close
Sort by
Journal Articles

Firstline Daratumumab Shows High Hematologic and Organ Response Rates in Advanced Cardiac AL Amyloidosis - a Retrospective Case Series

Georg Jeryczynski, MD, Antonia Eder, Eva-Maria Reitter, MD, Maria-Theresa Krauth, MD, Hermine Agis, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3123.
https://doi.org/10.1182/blood-2019-124681
Published: 2019
Journal Articles

Longitudinal Haemostatic Biomarker Trajectories Predict Cancer-Associated Venous Thromboembolism

Florian Posch, MD MSc, Julia Riedl, MD, Eva-Maria Reitter, MD, Peter Quehenberger, MD, Cihan Ay, MD, Ingrid Pabinger, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1095.
https://doi.org/10.1182/blood.V130.Suppl_1.1095.1095
Published: 2017
Journal Articles

Red Cell Distribution Width and Other Red Blood Cell Parameters in Patients with Cancer: Association with Risk of Venous Thromboembolism and Mortality

Julia Riedl, Florian Posch, Eva-Maria Reitter, Ernst Eigenbauer, Christine Marosi, Ilse Schwarzinger, Christoph Zielinski, Ingrid Pabinger, Cihan Ay, MD
Journal: Blood
Blood (2014) 124 (21): 2859.
https://doi.org/10.1182/blood.V124.21.2859.2859
Published: 2014
Journal Articles

Factor V Leiden Mutation Increases the Risk of Venous Thromboembolism in Cancer Patients – Results From the Vienna Cancer and Thrombosis Study (CATS).

Ingrid Pabinger, MD, Cihan Ay, MD, Daniela Dunkler, Johannes Thaler, Eva-Maria Reitter, Christine Marosi, Christoph Zielinski, Christine Mannhalter
Journal: Blood
Blood (2012) 120 (21): 2253.
https://doi.org/10.1182/blood.V120.21.2253.2253
Published: 2012